Association between hyperkalemia, RAASi non-adherence and outcomes in chronic kidney disease

Abstract

In a large cohort of CKD patients treated with RAASi, we observed that following hyperkalemia onset, non-adherence to RAASi medication can result in an increased risk of cardiovascular events and death.